Crescita Therapeutics Inc (CTX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 19,580 | 17,522 | 23,525 | 16,769 | 15,640 |
| Cost of Goods | 9,972 | 7,158 | 10,343 | 6,755 | 4,367 |
| Gross Profit | 9,608 | 10,364 | 13,182 | 10,014 | 11,273 |
| Operating Expenses | 12,823 | 12,320 | 12,653 | 10,733 | 9,718 |
| Operating Income | -3,215 | -1,956 | 529 | -719 | 1,555 |
| Interest Expense | 65 | 85 | 158 | 236 | 252 |
| Other Income | 516 | 511 | 33 | -54 | -783 |
| Pre-tax Income | -2,764 | -1,530 | 404 | -1,009 | 520 |
| Income Tax | -14 | 456 | -458 | 96 | 483 |
| Net Income Continuous | -2,750 | -1,986 | 862 | -1,105 | 37 |
| Net Income | $-2,750 | $-1,986 | $862 | $-1,105 | $37 |
| EPS Basic Total Ops | -0.14 | -0.10 | 0.04 | -0.05 | 0.00 |
| EPS Basic Continuous Ops | -0.14 | -0.10 | 0.04 | -0.05 | 0.00 |
| EPS Diluted Total Ops | -0.14 | -0.10 | 0.04 | -0.05 | 0.00 |
| EPS Diluted Continuous Ops | -0.14 | -0.10 | 0.04 | -0.05 | 0.00 |
| EBITDA(a) | $-1,333 | $61 | $2,033 | $606 | $2,263 |